线粒体DNA
生物
线粒体
抄写(语言学)
重编程
小RNA
癌症研究
基因
遗传学
线粒体生物发生
细胞生物学
转录因子
TFAM公司
线粒体分裂
尼泊尔卢比1
分子生物学
基因表达
哲学
语言学
作者
Song Fan,Tian Tian,Weixiong Chen,Xiao-Bin Lv,Xinyuan Lei,Hanqing Zhang,Sheng Sun,Lei Cai,Guokai Pan,Lile He,Zhanpeng Ou,Chunxiang Li,Dian Wang,Matthew C. Perez,Zhiming Tu,Soldano Ferrone,Bakhos A. Tannous,Jinsong Li
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2019-03-15
卷期号:79 (6): 1069-1084
被引量:73
标识
DOI:10.1158/0008-5472.can-18-2505
摘要
miRNAs that translocate from the nucleus to mitochondria are referred to as mitochondrial microRNAs (mitomiR). mitomiRs have been shown to modulate the translational activity of the mitochondrial genome, yet their role in mitochondrial DNA (mtDNA) transcription remains to be determined. Here we report that the mitomiR-2392 regulates chemoresistance in tongue squamous cell carcinoma (TSCC) cells by reprogramming metabolism via downregulation of oxidative phosphorylation and upregulation of glycolysis. These effects were mediated through partial inhibition of mtDNA transcription by mitomiR-2392 rather than through translational regulation. This repression required specific miRNA-mtDNA base pairing and Argonaute 2. mitomiR-2392 recognized target sequences in the H-strand and partially inhibited polycistronic mtDNA transcription in a cell-specific manner. A retrospective analysis of TSCC patient tumors revealed a significant association of miR-2392 and regulated mitochondrial gene expression with chemosensitivity and overall survival. The clinical relevance of targeted mitochondrial genes was consistently validated by The Cancer Genome Atlas RNA sequencing in multiple types of cancer. Our study revealed for the first time the role of mitomiR in mtDNA transcription and its contribution to the molecular basis of tumor cell metabolism and chemoresistance.Significance: These findings uncover a novel mechanism by which mitomiRNA regulates mitochondrial transcription and provide rationale for use of mitomiRNA and mtDNA-encoded genes to predict chemosensitivity and patient clinical prognosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI